Abstract:Alzheimer’s disease (AD) is a progressive neurodegenerative disorder and the leading cause of cognitive and behavioral impairment in industrialized societies. The cause of AD is unknown and the major risk factor for AD is age. About 5% of all AD cases have a genetic or familial cause however the vast majority of all AD cases (~95%) are of sporadic origin. Both the familial and the sporadic forms of AD share a common disease phenotype involving at least eight characteristic features including (i) evidence of uncontrolled oxidative stress; (ii) up-regulated pro-inflammatory signaling; (iii) changes in innate-immune signaling; (iv) the progressive accumulation of lesions including neurofibrillary tangles (NFT) and amyloid beta (Aβ)-containing senile plaques (SP); (v) significant synaptic signaling deficits; (vi) neurite and brain cell atrophy; (vii) progressively altered gene expression patterns that are different from healthy brain aging; and (viii) progressive cognitive impairment and dementia in the host. There is currently no cure or adequate clinical treatment for AD, and it remains unclear how AD originates and propagates throughout the brain and central nervous system (CNS). Results from recent genome-wide association studies (GWAS) indicate that a significant portion of AD-relevant gene signals are not located within gene coding regions suggesting the contribution of epigenetic or environmental factors to AD risk. The potential contribution of pathogenic microbes to aging and AD is becoming increasingly recognized (Miklossy, 2011; Cho and Blaser, 2012; Bhattacharjee and Lukiw, 2013; Poole et al., 2013; Heintz and Mair, 2014; Huang et al., 2014; Mancuso et al., 2014). Importantly, most of the changes seen in AD, such as inflammation, brain cell atrophy, immunological aberrations, amyloidogenesis, altered gene expression and cognitive deficits are also seen as a consequence of microbial infection (Cho and Blaser, 2012; Yatsunenko et al., 2012; Bhattacharjee and Lukiw, 2013; Foster and McVey Neufeld, 2013; Kim et al., 2013; Heintz and Mair, 2014; Mancuso et al., 2014). This brief communication will review some recent observations on the potential contribution of pathogens to neurological dysfunction, with specific reference to AD wherever possible.

Advances in the Study of the Pathology and Treatment of Alzheimer's Disease and Its Association with Periodontitis

Progress in molecular mechanisms of β-amyloid peptides in alzheimer's disease

The oral-brain axis: can periodontal pathogens trigger the onset and progression of Alzheimer's disease?

Research progress in the association between Alzheimer's disease and periodontitis

Advances in the prevention and treatment of Alzheimer's disease based on oral bacteria

Porphyromonas gingivalis and the pathogenesis of Alzheimer's disease

Research progress on the relation between chronic periodontitis and Alzheimer disease

[Relationship Between Oral Microbiota and Alzheimer's Disease].

How Periodontitis or Periodontal Bacteria Can Influence Alzheimer's Disease Features? A Systematic Review of Pre-Clinical Studies

How do periodontal infections affect the onset and progression of Alzheimer's disease?

The Periodontal Pathogen Fusobacterium Nucleatum Exacerbates Alzheimer’s Pathogenesis Via Specific Pathways

Recent Aspects of Periodontitis and Alzheimer's Disease—A Narrative Review

Porphyromonas gingivalis, neuroinflammation and Alzheimer's disease

Can Better Management of Periodontal Disease Delay the Onset and Progression of Alzheimer's Disease?

Advances in the Mechanism and Pharmacotherapies of Alzheimer's Disease

Advances in the Pathogenesis of Alzheimer’s Disease: Focusing on Tau-Mediated Neurodegeneration

Progress in pathogenesis and treatment of Alzheimer's disease

New Insights Into the Pathogenesis of Alzheimer's Disease

Pathogenic Microbes, the Microbiome, and Alzheimer’s Disease (AD)

Assessing the role of Porphyromonas gingivalis in periodontitis to determine a causative relationship with Alzheimer’s disease

Periodontal Infection Aggravates C1q-Mediated Microglial Activation and Synapse Pruning in Alzheimer’s Mice